What is Daybue, and what is it used for?
Daybue is a gene-silencing medicine (fosunetiksi?) used for Rett syndrome in patients with confirmed mutations (MECP2). It is administered by infusion. [1]
What “Daybue patent” is people usually referring to?
When people search “Daybue patent,” they typically mean one of these:
- The core patents that cover Daybue’s active ingredient and its formulation.
- Patents that cover manufacturing processes.
- Patents that cover the specific clinical use (for example, a particular genetic population).
- Any related exclusivity protections (patent term, patent extensions, or data exclusivity), which can affect when competitors can market alternatives even if a patent case is still ongoing. [1]
When do Daybue patents expire?
Patent expiration depends on the specific patent family and jurisdiction (the same drug often has multiple patents filed over time in different countries). Without the exact patent number(s) or the country (US, EP, UK, etc.), you cannot reliably calculate a single “Daybue patent expiry date.” The best way to pin this down is to look up the relevant patent(s) in the relevant national database and/or the regulator’s patent register, then check the filing/grant dates and any adjustments/extensions. [1]
Are there patent challenges or generic/biosimilar competition risks?
If competitors believe a Daybue patent is invalid or not infringed, they can challenge it through patent litigation. The outcome of those cases can shift the timeline for market entry of competing products. To assess the risk, you usually need the specific patent(s) asserted and the status in court (or settlement terms if applicable). [1]
How do I find the exact Daybue patent numbers quickly?
Search by:
- The company named on Daybue’s label (to locate the patent portfolio).
- The active ingredient name.
- The drug name in a country’s patent register (especially the US Orange Book for small molecules; other jurisdictions have their own registers).
- Any listed “patent numbers” attached to the product approval or regulatory submissions. [1]
If you tell me which country you care about (US vs EU/UK vs another) and whether you mean the main active-ingredient patent or a specific claimed use, I can help narrow down what to look for and how to interpret the expiry/exclusivity timing from the patent records.
Sources
[1] https://www.drugs.com/daybue.html